Form of 1995 Unit Purchase Warrant ---------------------------------- On March 17, 1998, Procept, Inc. ("Procept") completed a merger (the "Merger") with Pacific Pharmaceuticals, Inc. ("Pacific"). In accordance with the Agreement and Plan of Merger...Unit Purchase Warrant • March 31st, 1999 • Procept Inc • Biological products, (no disgnostic substances)
EX-4.5 4 dex45.htm MIDOCEAN SBR HOLDINGS, LLC UNIT PURCHASE WARRANT DATED AS OF MARCH 26, 2009Unit Purchase Warrant • May 5th, 2020 • Delaware
THE SECURITIES REPRESENTED BY THIS WARRANT AND ISSUABLE UPON EXERCISE HEREOF ARE SUBJECT TO RESTRICTIONS ON TRANSFER AND CERTAIN OTHER CONDITIONS, AS SPECIFIED IN THE OPERATING AGREEMENT DATED AS OF JANUARY 31, 2007, AS MAY BE AMENDED. NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THIS WARRANT OR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY BE MADE EXCEPT PURSUANT TO AND AS OTHERWISE PROVIDED IN SUCH OPERATING AGREEMENT, (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AND THE RULES AND REGULATIONS IN EFFECT THEREUNDER AND ALL APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS (SUCH FEDERAL AND STATE LAWS, THE “SECURITIES LAWS”) OR (B) IF THE COMPANY HAS BEEN FURNISHED WITH AN OPINION OF COUNSEL FOR THE HOLDER, WHICH OPINION AND COUNSEL SHALL BE REASONABLY SATISFACTORY TO THE COMPANY, TO THE EFFECT THAT SUCH TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION IS EXEMPT FROM THE PROVISIONS OF
FORM OF UNIT PURCHASE WARRANTUnit Purchase Warrant • September 10th, 2018 • Adial Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, ___________________ or his, her or its assigns (“Holder”), is entitled to purchase from Adial Pharmaceuticals, Inc., a Delaware corporation (the “Company”), at any time or from time to time during the period specified in Paragraph 2 hereof and subject to adjustment as provided herein, _________ units (each a “Unit” and collectively, the “Units”), with each Unit consisting of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and one warrant (each a “Common Warrant” and collectively, the “Common Warrants”) to purchase one share of Common Stock. The form of Common Warrant is attached hereto as Exhibit A. The exercise price per Unit is $5.00 (the “Exercise Price”). The term “Warrant Shares” as used herein, refers to the shares of Common Stock purchasable under this Warrant and the term “Common Warrant Shares” as used herein, refers to the shares of Common Stock purchasable under any Common Warrant that may be
94 EXHIBITI 1.3 No sale, offer to sell or transfer of the securities represented by this certificate or any interest therein shall be made unless a registration statement under the Federal Securities Act of 1933, as amended, with respect to such...Unit Purchase Warrant • February 22nd, 2000 • Exhaust Technologies Inc • Motor vehicle parts & accessories
UNIT PURCHASE WARRANT DUSKA THERAPEUTICS, INC.Unit Purchase Warrant • November 19th, 2004 • Duska Therapeutics, Inc. • Biological products, (no disgnostic substances) • Nevada
(but excluding the compensation of regular employees of the Public Company which shall be paid in any event by the Public Company).
Date of Issuance: February 16, 2005 Warrant to Purchase an Aggregate of 1,616,250 Units consisting of Common Stock and WarrantsUnit Purchase Warrant • March 17th, 2005 • Eautoclaims, Inc • Services-business services, nec • Florida
SPECTRE GAMING, INC. UNIT PURCHASE WARRANTUnit Purchase Warrant • December 2nd, 2004 • Spectre Gaming Inc • Services-telephone interconnect systems • Minnesota
Spectre Gaming, Inc., a Minnesota corporation (the “Company”), hereby agrees that, for value received, , or its assigns, is entitled, subject to the terms set forth below, to purchase from the Company at any time or from time to time after November 12, 2004, and before 5:00 P.M., Minneapolis, Minnesota time, on November 12, 2009, ( ) units (the “Units”), each unit consisting of one share of the Company’s common stock (the “Common Stock”), and a five-year warrant to purchase an additional share of Common Stock for $3.75 per share (the “Stock Warrant”), at an exercise price of $2.50 per Unit, subject to adjustment as provided herein (the “Exercise Price”).
